Meanwhile, we found that high expression of both ANLN and ASPM was associated with shorter survival time compared to low expression of ANLN and ASPM in the TCGA-BLCA and GSE13507 datasets (Figures 4E, F). The gene discussed is ANLN; the disease is bladder transitional cell carcinoma.